Literature DB >> 122813

Hepatitis B surface antigen and its subtypes in an institution for the mentally retarded.

E Perry, R K Chaudhary, T E Cleary, F R Roughley.   

Abstract

The prevalence of hepatitis B surface antigen (HBsAg) in 155 patients with Down's syndrome (DS) and 209 with other types of mental retardation (OMR) at Huronia Regional Centre, Orillia, Ontario was 34.8 and 5.3%, respectively. There was no significant difference in prevalence between males and females in either group of patients. In 75 matched pairs (DS-OMR) the HBsAg prevalence was 45% in DS and 8.3% in OMR males; in females 40% of those with DS were HBsAg-positive, whereas all the OMR residents were negative. The prevalence of HBsAg in both DS and OMR groups was higher in those admitted in early childhood and in those who had resided in the institution for more than 10 years. In all 54 HBsAg-positive DS patients the antigen subtype was ad. Among the 11 HBsAg-positive OMR patients the subtype was ad in 10 cases and ay in 1.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 122813      PMCID: PMC1956009     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  18 in total

1.  Additional specificities of Australia antigen and the possible identification of hepatitis carriers.

Authors:  C Levene; B S Blumberg
Journal:  Nature       Date:  1969-01-11       Impact factor: 49.962

2.  Anicteric hepatitis associated with Australia antigen. Occurrence in patients with Down's syndrome.

Authors:  A I Sutnick; W T London; B J Gerstley; M M Cronlund; B S Blumberg
Journal:  JAMA       Date:  1968-09-02       Impact factor: 56.272

3.  A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis.

Authors:  B S Blumberg; B J Gerstley; D A Hungerford; W T London; A I Sutnick
Journal:  Ann Intern Med       Date:  1967-05       Impact factor: 25.391

4.  Development and distribution of hemagglutinating antibody against the hepatitis B antigen in institutionalized populations.

Authors:  W Szmuness; A M Prince; G F Etling; R Pick
Journal:  J Infect Dis       Date:  1972-11       Impact factor: 5.226

5.  Two antigenic specificities in the Australia antigen.

Authors:  I D Gust
Journal:  Aust J Exp Biol Med Sci       Date:  1971-12

6.  The epidemiology of serum hepatitis (SH) infections: a controlled study in two closed institutions.

Authors:  W Szmuness; A M Prince
Journal:  Am J Epidemiol       Date:  1971-12       Impact factor: 4.897

7.  Studies in Down's syndrome. I. Genetic predisposition to become a carrier of the Au-SH antigen?

Authors:  C Rittner; E Schwinger; F G Stockhausen; J Dufkova
Journal:  Vox Sang       Date:  1970 Sep-Oct       Impact factor: 2.144

8.  Immune response to hepaitis virus type B in Down's syndrome and other mentally retarded patients.

Authors:  F B Hollinger; R K Goyal; T Hersh; H C Powell; R J Schulman; J L Malnick
Journal:  Am J Epidemiol       Date:  1972-04       Impact factor: 4.897

9.  Subdeterminants d and y of hepatitis B antigen as epidemiologic markers.

Authors:  J W Mosley; V M Edwards; J E Meihaus; A G Redeker
Journal:  Am J Epidemiol       Date:  1972-06       Impact factor: 4.897

10.  Hepatitis B antigen: distribution of ad and ay subtypes in blood donors and hepatitis patients.

Authors:  E Perry; R K Chaudhary
Journal:  Can Med Assoc J       Date:  1973-11-03       Impact factor: 8.262

View more
  2 in total

1.  Hepatitis B and C infection in an institution for the mentally handicapped.

Authors:  D Torre; M Giola; C Zeroli; G Ferrario; M Broggini; L Agrifoglio; V Bottà
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553

Review 2.  Hepatitis in nursing homes. Incidence and management strategies.

Authors:  A Floreani; M Chiaramonte
Journal:  Drugs Aging       Date:  1994-08       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.